4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-115695
Options or other derivatives
- Chief Operating Officer acquired 18,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bruno Julianne · Chief Operating Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-16 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +18,333 | 18,333 | D |
Loading xslF345X05/ownership.xml…